MENLO PARK, Calif.,
July 13, 2015 /PRNewswire/ --
BioPharmX Corporation (NYSE MKT: BPMX), is pleased to announce
that the company's chief executive officer and its president are
invited by the New York Stock Exchange (NYSE) to ring the NYSE
Opening Bell® on Wednesday, July 15,
2015 to celebrate its listing. Its stock was uplisted
and commenced trading on June 25,
2015.
"BioPharmX is proud to ring the opening bell on behalf of
our employees, investors and other supporters. We found that the
NYSE MKT, the premier U.S. equities market for listing and trading
early stage companies, is committed to providing a strong platform
for growth," said Jim Pekarsky,
chief executive officer of BioPharmX Corporation. "We look forward
to the great exposure the NYSE MKT will give us to a larger group
of investors while increasing awareness of our pipeline of products
being developed to address significant, unmet medical needs."
Jim Pekarsky and BioPharmX
President, Anja Krammer, will both
be present for this important ceremony.
NYSE MKT is a fully integrated trading venue within the NYSE
community and leverages the NYSE's advanced and innovative market
model to offer a premier venue for listing and trading the stocks
of small companies. The venue utilizes the trading, connectivity
and routing technologies of the NYSE platform and offers superior
price discovery, superior liquidity and reduced trading volatility.
Listed companies benefit from issuer-selected Designated Market
Makers (DMM) that utilize world-class NYSE trading systems to
discover and improve prices, dampen volatility, add liquidity and
enhance value. In addition, NYSE MKT-listed companies gain access
to the brand visibility and are eligible for the issuer services
enjoyed by the NYSE community.
The NYSE Opening Bell will ring at 9:30
a.m. EDT and can be viewed live on the NYSE website
at https://nyse.nyx.com/the-bell/todays-bells-live. Photos and
video of the NYSE Bell Ringing Ceremony will also be available,
courtesy of the NYSE, on Facebook (NYSE), Twitter (@NYSE and
@NYSECam), and Livestream.
About BioPharmX Corporation
BioPharmX Corporation (NYSE MKT: BPMX) is a Silicon Valley-based
specialty pharmaceutical company, which seeks to provide products
through proprietary platform technologies for prescription,
over-the-counter (OTC), and supplement applications in the health
and wellness markets, including women's health and dermatology. To
learn more about BioPharmX, visit www.BioPharmX.com.
Forward-Looking Statements
Statements in this news
release relating to the business of BioPharmX, which are not
historical facts, are "forward-looking statements." These
forward-looking statements may be identified by words such as
"expect," "anticipate," "believe," or similar expressions that are
intended to identify such forward-looking statements. All
forward-looking statements are expressly qualified in their
entirety by this cautionary statement and the risks and other
factors detailed in the company's filings with the Securities and
Exchange Commission (SEC). These statements are based upon the
current expectations and beliefs of management and are subject to
certain risks and uncertainties that could cause actual results to
differ materially from those described in the forward-looking
statements. Given these risks and uncertainties, you are cautioned
not to place undue reliance on such forward-looking statements.
The forward-looking statements included in this news release
are made only as of the date hereof and the company undertakes no
obligation to publicly update or revise any forward-looking
statements, whether as a result of new information, future events
or otherwise, except as may be required under applicable securities
law.
BioPharmX is a pending trademark of BioPharmX Inc. All
other brand and product names are trademarks or registered
trademarks of their respective holders.
Logo -
http://photos.prnewswire.com/prnh/20150711/235327LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/biopharmx-to-ring-new-york-stock-exchange-opening-bell-to-celebrate-its-listing-on-nyse-mkt-300111889.html
SOURCE BioPharmX Corporation